Lantern PharmaLTRN
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 32 institutions reported holding Lantern Pharma Inc. (LTRN) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 5 sold out. The largest holders were BIOS Capital Management, LP ($3.9M), Vanguard Group Inc. ($1.2M) and CM Management, LLC ($638K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lantern Pharma Inc.
- CUSIP
- 51654W101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $208K |
| Exits | 5 | $121K |
All 13F filers, Q3 2024 → Q4 2024: 120,293 shares bought and 169,131 shares sold, net −48,838 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| BIOS Capital Management, LP | 4.09% | — | 1,207,709 | $3.9M |
| Vanguard Group Inc. | 0.00% | No change | 363,720 | $1.2M |
| CM Management, LLC | 0.57% | Add +8.1% | 200,000 | $638K |
| Renaissance Technologies | 0.00% | Add +3.9% | 87,300 | $278K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.5% | 86,973 | $278K |
| NewEdge Advisors, LLC | 0.00% | Reduce -50.2% | 68,359 | $218K |
| Voss Capital, LP | 0.01% | New | 50,000 | $160K |
| BlackRock, Inc. | 0.00% | Add +0.3% | 40,596 | $130K |
| Citadel Advisors | 0.00% | Add +1645.8% | 37,587 | $120K |
| Redmond Asset Management, LLC | 0.03% | Reduce -4.2% | 37,270 | $119K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.7% | 36,549 | $117K |
| Westside Investment Management, Inc. | 0.02% | No change | 30,650 | $98K |
| Horizon Kinetics Asset Management LLC | 0.00% | Add +4.4% | 28,791 | $92K |
| Sigma Planning Corp | 0.00% | Reduce -0.7% | 28,450 | $91K |
| UBS Group AG | 0.00% | Add +3.0% | 27,684 | $88K |
| Bank of New York Mellon Corp | 0.00% | No change | 26,482 | $84K |
| Susquehanna International Group, LLP | 0.00% | Add +20.2% | 26,301 | $84K |
| DAVENPORT & Co LLC | 0.00% | Reduce -52.0% | 25,814 | $82K |
| State Street Corp. | 0.00% | No change | 23,652 | $75K |
| Two Sigma Investments, LP | 0.00% | Reduce -51.8% | 16,545 | $53K |
| Perigon Wealth Management, LLC | 0.00% | Reduce -49.5% | 14,600 | $53K |
| Sanctuary Advisors, LLC | 0.00% | New | 10,000 | $48K |
| Northern Trust Corp. | 0.00% | No change | 12,813 | $41K |
| Wells Fargo & Company | 0.00% | Reduce -42.5% | 4,608 | $15K |
| SBI Securities Co., Ltd. | 0.00% | — | 2,108 | $7K |
| Curio Wealth, LLC | 0.00% | — | 2,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -16.6% | 1,263 | $4K |
| Richards, Merrill & Peterson, Inc. | 0.00% | — | 975 | $3K |
| Morgan Stanley | 0.00% | Add +0.2% | 601 | $2K |
| Parkside Financial Bank & Trust | 0.00% | No change | 260 | $830 |
| Allworth Financial LP | 0.00% | No change | 100 | $448 |
| Bank of America Corp. | 0.00% | No change | 65 | $207 |
"% of holder's portfolio" is LTRN's weight in each manager's 13F, not the share of Lantern Pharma Inc. the manager owns.